Antibody Engineering & Therapeutics Europe 2026, Basel, Switzerland, May 27-29

‍

Don't miss genOway's presentation:

‍

🕛 Friday, 29 May 2026 12:30 - 13:00

📍 Congress Center, Basel Switzerland

🎓 Presenter: Kader Thiam, CSO & SVP – Discovery, Preclinical Models & Services

📢 Presentation Title: Enhancing the Translational Relevance of Immunotherapies Efficacy and Safety in Preclinical Models

• Outlining genO-BRGSF-HIS mice: a CD34⁺-reconstituted model with functional human lymphoid and myeloid compartments, without side effects
• Evidencing the recruitment of human immune cells to tumor microenvironment, as well as their activation status
• Showcasing immunocompetent mouse models expressing humanized Fc receptors as tools for translational assessment of engineered antibodies

‍